Georgetown University School of Medicine, a medical school opened in 1851, is one of Georgetown University's five graduate schools. It is located on Reservoir Road in the Georgetown neighborhood of Washington, DC, adjacent to the University's main campus.

During the past decade, Georgetown University School of Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgetown University School of Medicine" #1 sponsor was "TaiMed Biologics Inc." with 2 trials, followed by "University of Massachusetts, Worcester" with 2 trials sponsored, "Advanced Bionics" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Georgetown University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgetown University School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Brown University" with 1 trials as a collaborator, "Creighton University" with 1 trials as a collaborator, "Georgetown University" with 1 trials as a collaborator and "Harvard School of Public Health (HSPH)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Georgetown University School of Medicine" are "HIV" (2 trials), "Interstitial Lung Disease" (2 trials), "Ear Diseases" (1 trials), "Hearing Disorders" (1 trials) and "Hearing Loss" (1 trials). Many other conditions were trialed in "Georgetown University School of Medicine" in a lesser frequency.

Most popular intervention types in "Georgetown University School of Medicine" are "Drug" (4 trials), "Behavioral" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ibalizumab" (2 trials), "Booster Session" (1 trials), "Cyclophosphamide" (1 trials) and "EAS sound processor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgetown University School of Medicine" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Georgetown University School of Medicine". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Georgetown University School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Georgetown University School of Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".